Q4 2023 Holdings
Filed 2024-02-13 | 39 holdings | $160.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Karuna Therapeutics Inc | COM | 48576A100 | $71.4M | 225,688 | 44.5% |
| Illumina Inc(ILMN) | COM | 452327109 | $16.6M | 119,196 | 10.3% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $11.9M | 368,665 | 7.4% |
| Oculis Holding AG(OCS) | ORDINARY SHARES | H5870P102 | $5.8M | 518,933 | 3.6% |
| Exscientia PLC | ADS | 30223G102 | $5.5M | 859,892 | 3.4% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $5.0M | 263,940 | 3.1% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $4.9M | 106,680 | 3.1% |
| Somalogic Inc(SLGCUSD) | CLASS A COM | 83444K105 | $4.3M | 1,696,558 | 2.7% |
| Merus N V | COM | N5749R100 | $3.8M | 137,038 | 2.3% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $3.7M | 304,277 | 2.3% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $2.8M | 96,100 | 1.8% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $2.7M | 274,488 | 1.7% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $2.2M | 12,022 | 1.4% |
| Incyte Corp(INCY) | COM | 45337C102 | $2.0M | 32,022 | 1.3% |
| Geron Corp(GERN) | COM | 374163103 | $1.9M | 913,550 | 1.2% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $1.8M | 40,070 | 1.1% |
| Rani Therapeutics Hldgs Inc(RANI) | COM CL A | 753018100 | $1.6M | 493,584 | 1.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $1.6M | 184,739 | 1.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $1.5M | 64,200 | 1.0% |
| Bolt Biotherapeutics Inc(BOLT1EUR) | COM | 097702104 | $1.3M | 1,166,952 | 0.8% |
| Aerovate Therapeutics Inc | COM | 008064107 | $1.1M | 47,936 | 0.7% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $1.1M | 47,150 | 0.7% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $938.8K | 29,984 | 0.6% |
| Entrada Therapeutics Inc(TRDA) | COM | 29384C108 | $740.6K | 49,082 | 0.5% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $624.6K | 41,950 | 0.4% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $580.8K | 40,000 | 0.4% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $544.0K | 1,430 | 0.3% |
| Athira Pharma Inc | COM | 04746L104 | $437.4K | 180,000 | 0.3% |
| Eargo Inc | COM NEW | 270087208 | $383.1K | 147,904 | 0.2% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $353.4K | 370,950 | 0.2% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $348.6K | 3,615 | 0.2% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $273.5K | 1,182 | 0.2% |
| Affimed N V | COM | N01045108 | $232.8K | 372,472 | 0.1% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $106.9K | 17,847 | 0.1% |
| Galera Therapeutics Inc(GRTX) | COM | 36338D108 | $89.2K | 613,223 | 0.1% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $71.5K | 12,521 | 0.0% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $59.7K | 19,622 | 0.0% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $55.0K | 62,106 | 0.0% |
| Cerus Corp(CERS) | COM | 157085101 | $30.6K | 14,172 | 0.0% |